NCT05729607
Vertical Soft Tissue Augmentation With CTG vs ADM
StatusTerminated
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: Recruitment insufficient Show 5 more changesShow less
- Eligibility criteria expanded, about 12 words
- Final enrollment: 14 participants (planned 28)
- Primary completion date changed from estimate of Feb 27, 2027 to Oct 27, 2026
- Secondary endpoints: details revised at 2 of 6 entries
- Site details revised
- Notable Primary completion date: Feb 27, 2026 to Feb 27, 2027
- Study completion date: Nov 27, 2026 to Nov 27, 2027
- Site contact updated
- Notable Primary completion date: Feb 27, 2025 to Feb 27, 2026
- Study completion date: Nov 27, 2025 to Nov 27, 2026
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of May 1, 2023 to May 26, 2023
- Site details revised
- Notable Start date: Mar 1, 2023 to May 1, 2023v3
- Notable Primary endpoint revised
- Secondary endpoints revised (6)
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Change in Soft tissue dehiscence depth
Timeframe: 12 months
Secondary (6)
Complete peri-implant soft tissue dehiscence (PSTD) coverage
mean peri-implant soft tissue dehiscence (PSTD) coverage
Mucosal thickness changes
3D Volumetric changes
Post-operative pain
Show 1 moreShow less
Professional esthetic assessment (IDES)
Arms and interventions
Connective tissue graftActive comparator
Autogenous connective tissue graft harvested from the palate as a free gingival graft and then de-epithelialized
Dermal matrix + EMDExperimental
Acellular dermal matrix and enamel matrix derivative
Procedures: Vertical soft tissue augmentation
Sites
1 site in 1 country
- Harvard School of Dental MedicineBoston, Massachusetts, United States